Cite
LTX-315 triggers anticancer immunity by inducing MyD88-dependent maturation of dendritic cells.
MLA
Xiao-Qing Li, et al. “LTX-315 Triggers Anticancer Immunity by Inducing MyD88-Dependent Maturation of Dendritic Cells.” Frontiers in Immunology, Mar. 2024, pp. 01-15. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1332922.
APA
Xiao-Qing Li, Takahiro Yamazaki, Tianzhen He, Alam, M. M., Jia Liu, Trivett, A. L., Sveinbjørnsson, B., Rekdal, Ø., Galluzzi, L., Oppenheim, J. J., & De Yang. (2024). LTX-315 triggers anticancer immunity by inducing MyD88-dependent maturation of dendritic cells. Frontiers in Immunology, 01-15. https://doi.org/10.3389/fimmu.2024.1332922
Chicago
Xiao-Qing Li, Takahiro Yamazaki, Tianzhen He, Md Masud Alam, Jia Liu, Anna L. Trivett, Baldur Sveinbjørnsson, et al. 2024. “LTX-315 Triggers Anticancer Immunity by Inducing MyD88-Dependent Maturation of Dendritic Cells.” Frontiers in Immunology, March, 01-15. doi:10.3389/fimmu.2024.1332922.